Renovis Surgical received FDA 510(k) clearance to market the Tesera® X Lateral Interbody Fusion system. The device completes the company’s 3D-printed titanium interbody product lineup which includes implants for ALIF, TLIF, PLIF, ACDF and standalones.
Tesera X uses Renovis’ 3D-printed porous architecture, which is made using additively manufactured titanium alloy to create a roughened, highly porous surface to support bone attachment and ingrowth.
Renovis Surgical received FDA 510(k) clearance to market the Tesera® X Lateral Interbody Fusion system. The device completes the company's 3D-printed titanium interbody product lineup which includes implants for ALIF, TLIF, PLIF, ACDF and standalones.
Tesera X uses Renovis' 3D-printed porous architecture, which is made using additively...
Renovis Surgical received FDA 510(k) clearance to market the Tesera® X Lateral Interbody Fusion system. The device completes the company’s 3D-printed titanium interbody product lineup which includes implants for ALIF, TLIF, PLIF, ACDF and standalones.
Tesera X uses Renovis’ 3D-printed porous architecture, which is made using additively manufactured titanium alloy to create a roughened, highly porous surface to support bone attachment and ingrowth.
Copy to clipboard 
